麻醉症治疗坚持的障碍 麻醉症治疗坚持的障碍
Benedicte Marie Finger1, Ashley M Bourke2, Gert Jan Lammers3
1Center for Narcolepsy and Hypersomnias, Professorship for Narcolepsy and Hypersomnolence Research, Department of Medicine, University Witten/Herdecke, Witten, DE, Germany.
Sleep medicine
|July 9, 2024
概括
治疗坚持障碍在麻醉中普遍存在,遗忘,抑郁和副作用是主要问题. 解决这些因素对于有效的麻醉症管理和改善患者的治疗结果至关重要.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 精神病学是一个精神病学.
背景情况:
- 麻醉症治疗的坚持是复杂的,受到嗜睡,认知问题和精神病相关疾病的影响.
- 管理涉及非药理和药理方法,遵守会影响治疗的有效性.
研究的目的:
- 确定影响麻醉症治疗坚持的因素.
- 确定麻醉症患者坚持最重要的障碍.
主要方法:
- 一项在线调查评估了麻醉症患者的人口统计,临床数据和药物使用情况.
- 使用了坚持障碍问卷 (ABQ),爱普沃思睡眠度量表 (ESS) 和患者健康问卷 (PHQ-9).
主要成果:
- 在243名麻醉症患者中,89%的人报告了坚持障碍,最常见的是遗忘 (77%),抑郁 (57%) 和副作用 (49%).
- 药物的副作用导致78%受影响的患者停止治疗.
- 在坚持障碍,抑郁症严重程度 (PHQ-9) 和过度白天嗜睡 (ESS) 之间发现了显著的相关性.
结论:
- 坚持障碍在麻醉中是常见的和多样化的,通常与EDS,认知缺陷和抑郁症有关.
- 解决副作用和改善EDS和抑郁症的管理对于提高治疗坚持至关重要.
- 有效的沟通和积极的管理是优化麻醉症护理的关键.
相关概念视频
01:07Narcolepsy
101
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
101
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:19Management of Insomnia
243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
166
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
166
01:14CNS Depressants: Barbiturates and Benzodiazepines
243
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
243